This inventor holds 3 USPTO granted patents. Top assignee: The Procter Gamble Company. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Thomas Prosser Demuth, Jr: Innovator in Biochemical Research
Introduction
Thomas Prosser Demuth, Jr. is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of biochemical research, particularly in the development of enzyme inhibitors. With a total of 3 patents to his name, Demuth has established himself as a key figure in his area of expertise.
Latest Patents
Among his latest patents, Demuth has focused on interleukin-1β converting enzyme inhibitors. His inventions relate to novel compounds and compositions that include these compounds, showcasing their potential uses in various applications. The specific formula for these inhibitors is a testament to his innovative approach in addressing biochemical challenges.
Career Highlights
Demuth is currently associated with The Procter & Gamble Company, where he applies his expertise in research and development. His work at this prominent company allows him to contribute to advancements in health and wellness products, leveraging his knowledge in enzyme inhibitors.
Collaborations
Throughout his career, Demuth has collaborated with talented individuals such as Steven Victor O'Neil and Michael Christopher Laufersweiler. These partnerships have likely enhanced his research efforts and broadened the impact of his inventions.
Conclusion
Thomas Prosser Demuth, Jr. exemplifies the spirit of innovation in the field of biochemical research. His contributions through patents and collaborations continue to influence advancements in health-related technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile